PAMU
AGN

Pictet Asset Management (UK)’s Allergan Inc AGN Stock Holding History

Pictet Asset Management (UK)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-186,204
Closed -$39.6M – 917
2014
Q4 		$39.6M Sell
186,204
-4,447
-2% -$884K 0.18% 153
2014
Q3 		$34M Sell
190,651
-9,249
-5% -$1.54M 0.16% 162
2014
Q2 		$33.8M Sell
199,900
-3,800
-2% -$592K 0.16% 164
2014
Q1 		$25.3M Buy
203,700
+14,070
+7% +$1.71M 0.13% 186
2013
Q4 		$21.1M Sell
189,630
-27,500
-13% -$2.63M 0.11% 220
2013
Q3 		$19.6M Buy
217,130
+6,500
+3% +$584K 0.11% 213
2013
Q2 		$17.7M Buy
+210,630
New +$21.9M 0.1% 209

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Pictet Asset Management (UK)'s AGN Position: Q1 2015 in Review

Pictet Asset Management (UK) sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 186,204 shares — an estimated $39.6M sold.

Pictet Asset Management (UK) first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $39.6M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Pictet Asset Management (UK) reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 186,204 Allergan Inc shares in Q1 2015, an estimated $39.6M.
  • Pictet Asset Management (UK) first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Pictet Asset Management (UK)'s Allergan Inc position peaked at $39.6M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2015, filed 13 May 2015.